Abundance of apoptotic neoplastic cells in diagnostic biopsy samples is not a prognostic factor in childhood primitive neuroectodermal tumors of the central nervous system

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 1, 2001, Pages 25-29

  Grotzer, Michael A ^a   Janss, Anna J ^a   Fung, Kar Ming ^d,e   Sutton, Leslie N ^b   Zhao, Huaqing ^a   Trojanowski, John Q ^d,e   Rorke, Lucy B ^c   Phillips, Peter C ^a  

^a Division of Oncology   (United States)

^b Division of Neurosurgery   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Department of Pathology and Laboratory Medicine ^*  (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Medulloblastoma; Primitive neuroectodermal tumor; Prognosis; Tunel

Indexed keywords

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; HUMAN; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; STAINING; SURVIVAL RATE; TISSUE SECTION; TUMOR CELL;

APOPTOSIS; BIOPSY; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; MENINGEAL NEOPLASMS; NEOPLASM STAGING; NEUROECTODERMAL TUMORS, PRIMITIVE; PROGNOSIS; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE;

EID: 0035147197     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200101000-00007     Document Type: Article

References (29)

1. Soini Y, Pääkö P, Lehto V-P. Histopathological evaluation of apoptosis in cancer. Am J Pathol 1998; 153: 1041-53.
2. Wikstrand CJ, Fung K-M, Trojanowski JQ, et al. Antibodies and molecular immunology. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell & Rubinstein’s Pathology of Tumors of the Nervous System, ed 6. London: Arnold, 1998;251-304.
3. Aihara M, Scardino PT, Truong LD, et al. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 1995; 75: 522-9.
4. Komaki R, Fuji T, Perkins P, et al. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 36: 601-5.
5. Ikeguchi M, Cai J, Yamane N, et al. Clinical significance of spontaneous apoptosis in advanced gastric adenocarcinoma. Cancer 1999; 85: 2329-35.
6. Hirvikoski P, Kumulainen E, Virtaniemi J, et al. Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer 1999; 35: 231-7.
7. Wu J, Shen ZZ, Lu JS, et al. Prognostic role of p27Kip1 and apoptosis in human breast cancer. Br J Cancer 1999; 79: 1572-8.
8. Schiffer D, Dutto A, Cavalla P, et al. Role of apoptosis in the prognosis of oligodendrogliomas. Neurochem Int 1997; 31: 245-50.
9. Carroll RS, Zhang J, Chauncey BW, et al. Apoptosis in astrocytic neoplasms. Acta Neurochir 1997; 139: 845-50.
10. Schiffer D, Cavalla P, Migheli A, et al. Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 1995; 195: 81-4.
11. Schiffer D, Cavalla P, Chio A, et al. Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 1994; 87: 362-70.
12. Schubert TEO, Cervos-Navarro J. The histopathological and clinical relevance of apoptotic cell death in medulloblastoma. J Neuropath Exp Neur 1998; 57: 10-5.
13. Haslam RHA, Lamborn KR, Becker LE, et al. Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma. J Pediatr Hematol Oncol 1998; 20: 520-7.
14. Migheli A, Attanasio A, Schiffer D. Ultrastructural detection of DNA strand breaks in apoptotic neural cells by in situ end-labeling techniques. J Pathol 1995; 176: 27-35.
15. Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994; 81: 690-8.
16. Gavrieli Y, Sherman Y, Ben-Sasson A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
17. Lipponen P, Aaltomaa S, Kosma V-M, et al. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994; 30A: 2068-73.
18. Janss AJ, Yachnis AT, Silber JH, et al. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann Neurol 1996; 39: 481-9.
19. Evans AE, Jenkin DT, Sposto R, et al. The treatment of medulloblastoma. J Neurosurg 1990; 72: 572-82.
20. Garton GR, Schomberg PJ, Scheithauer BW, et al. Medulloblastoma - prognostic factors and outcome of treatment: review of the Mayo clinic experience. Mayo Clin Proc 1990; 65: 1077-1086.
21. Weil MD, Lamborn K, Edwards MS, et al. Influence of a child’s sex on medulloblastoma outcome. JAMA 1998; 13: 1474-6.
22. Albright AL, Wisoff JH, Zeltzer PM, et al. Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 1996; 38: 265-71.
23. Cohen BH, Zeltzer PM, Boyett JM. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Children’s Cancer Group randomized trial. J Clin Oncol 1995; 13: 1687-96.
24. Berry MP, Jenkin RDT, Keen CW, et al. Radiation treatment for medulloblastoma. J Neurosurg 1981; 55: 43-51.
25. Merchant TE, Wang M-H, Haida T, et al. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol 1996; 36: 29-35.
26. Pezzotta S, Cordero di Montezemolo L, Knerich R, et al. CNS-85 trial: a cooperative pediatric CNS tumor study: results of treatment of medulloblastoma patients. Childs Nerv Syst 1996; 12: 87-96.
27. Sure U, Berghorn WJ, Bertalanffy H, et al. Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir 1995; 132: 59-65.
28. Tait DM, Thornton-Jones H, Bloom HJG, et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990; 26: 464-9.
29. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 1999; 17: 832-45.